Semaglutide vs Liraglutide for Weight Reduction
hosted byConnect Educate Impact (CEI)
Semaglutide vs Liraglutide for Weight Reduction is organized by Connect Educate Impact (CEI).
Initial Release Date: July 20, 2022
Planned Expiration Date: July 20, 2025
Description:
The STEP 8 trial compares the efficacy of once-daily subcutaneous liraglutide with weekly semaglutide in reducing weight in overweight and obese patients. Take this Journal Club CE to learn the strengths and limitations of the study, and how the findings impact practice and patient outcomes.
Objectives:
Upon successful completion of this application-based course, pharmacists and pharmacy students should be able to:
• Compare the efficacy of weekly semaglutide and daily liraglutide on reducing weight in persons overweight and obese.
• Compare the adverse effects of semaglutide and liraglutide when used in persons overweight and obese.
• Describe the strengths and limitations of the STEP 8 Randomized Clinical Trial.
• Identify patients who may be a candidate to receive semaglutide for weight management
• Select the best glucagon-like peptide-1 analog for weight management in a given patient
